Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Sunshine Biopharma (SBFM) over the last 12 years, with Q3 2025 value amounting to $253.0.

  • Sunshine Biopharma's Other Non Operating Income fell 9833.04% to $253.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$337359.0, marking a year-over-year decrease of 21401.81%. This contributed to the annual value of -$44082.0 for FY2024, which is 1789265.31% down from last year.
  • Latest data reveals that Sunshine Biopharma reported Other Non Operating Income of $253.0 as of Q3 2025, which was down 9833.04% from $1940.0 recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Other Non Operating Income registered a high of $286535.0 during Q2 2024, and its lowest value of -$340003.0 during Q4 2024.
  • In the last 5 years, Sunshine Biopharma's Other Non Operating Income had a median value of $130.5 in 2021 and averaged $1123.1.
  • Over the last 5 years, Sunshine Biopharma's Other Non Operating Income had its largest YoY gain of 10988352.49% in 2024, and its largest YoY loss of 87170256.41% in 2024.
  • Quarter analysis of 5 years shows Sunshine Biopharma's Other Non Operating Income stood at -$7909.0 in 2021, then soared by 100.32% to $25.0 in 2022, then crashed by 256.0% to -$39.0 in 2023, then tumbled by 871702.56% to -$340003.0 in 2024, then surged by 100.07% to $253.0 in 2025.
  • Its Other Non Operating Income stands at $253.0 for Q3 2025, versus $1940.0 for Q2 2025 and $451.0 for Q1 2025.